Hyperosmolar hyperglycemic state primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hyperosmolar hyperglycemic state}} | {{Hyperosmolar hyperglycemic state}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{HS}} | ||
==Overview== | ==Overview== | ||
| Line 7: | Line 7: | ||
==Primary Prevention== | ==Primary Prevention== | ||
Effective measures for the primary prevention of hyperosmolar hyperglycemic state include:<ref name="pmid18551826">{{cite journal |vauthors=Vanelli M, Scarabello C, Fainardi V |title=Available tools for primary ketoacidosis prevention at diabetes diagnosis in children and adolescents. "The Parma campaign" |journal=Acta Biomed |volume=79 |issue=1 |pages=73–8 |year=2008 |pmid=18551826 |doi= |url=}}</ref><ref name="urlManagement of Diabetic Ketoacidosis - American Family Physician">{{cite web |url=http://www.aafp.org/afp/1999/0801/p455.html |title=Management of Diabetic Ketoacidosis - American Family Physician |format= |work= |accessdate=}}</ref><ref name="pmid4085289">{{cite journal |vauthors=Zhou HC |title=[Preliminary studies of cardiac function in pre-eclamptic patients with echocardiography and systolic time intervals] |language=Chinese |journal=Zhonghua Fu Chan Ke Za Zhi |volume=20 |issue=5 |pages=266–9, 317 |year=1985 |pmid=4085289 |doi= |url=}}</ref><ref name="urlwww.aace.com">{{cite web |url=https://www.aace.com/files/position-statements/SGLT-2-position-statement.pdf |title=www.aace.com |format= |work= |accessdate=}}</ref> | |||
* '''Recognition of early signs:''' | * '''Recognition of early signs:''' | ||
** [[Vomiting]] | ** [[Vomiting]] | ||
| Line 29: | Line 29: | ||
** Possible out-of-home placement | ** Possible out-of-home placement | ||
** Never discontinue [[insulin]] during illness without contacting health care provider | ** Never discontinue [[insulin]] during illness without contacting health care provider | ||
** Having medication available to treat an infection | ** Having [[medication]] available to treat an [[infection]] | ||
==References== | ==References== | ||
| Line 36: | Line 36: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
| |||
[[Category:Emergency medicine]] | |||
Latest revision as of 18:00, 17 October 2017
|
Hyperosmolar hyperglycemic state Microchapters |
|
Differentiating Hyperosmolar hyperglycemic state from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hyperosmolar hyperglycemic state primary prevention On the Web |
|
American Roentgen Ray Society Images of Hyperosmolar hyperglycemic state primary prevention |
|
Hyperosmolar hyperglycemic state primary prevention in the news |
|
Blogs on Hyperosmolar hyperglycemic state primary prevention |
|
Risk calculators and risk factors for Hyperosmolar hyperglycemic state primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]
Overview
Effective measures for the primary prevention of hyperosmolar hyperglycemic state (HHS) include recognition of early signs of HHS, implementation of early and aggressive interventions (especially in patients with recurrent episodes of (HHS), tight glycemic control especially in patients with chronic illnesses, and education of patients and their family members.
Primary Prevention
Effective measures for the primary prevention of hyperosmolar hyperglycemic state include:[1][2][3][4]
- Recognition of early signs:
- Early recognition of inciting event:
- Missed insulin dose or error in dosing
- Intercurrent illness, especially infection
- Psychologic stress
- Surgery or trauma
- Early intervention:
- Enhanced and more frequent monitoring of blood glucose
- Increased fluid intake
- Seek advice from health care team
- Aggressive intervention in patients with recurrent episodes:
- Psychiatric evaluation
- Individual and family evaluation/intervention
- Continuous subcutaneous insulin infusion helpful in some patients
- Possible out-of-home placement
- Never discontinue insulin during illness without contacting health care provider
- Having medication available to treat an infection
References
- ↑ Vanelli M, Scarabello C, Fainardi V (2008). "Available tools for primary ketoacidosis prevention at diabetes diagnosis in children and adolescents. "The Parma campaign"". Acta Biomed. 79 (1): 73–8. PMID 18551826.
- ↑ "Management of Diabetic Ketoacidosis - American Family Physician".
- ↑ Zhou HC (1985). "[Preliminary studies of cardiac function in pre-eclamptic patients with echocardiography and systolic time intervals]". Zhonghua Fu Chan Ke Za Zhi (in Chinese). 20 (5): 266–9, 317. PMID 4085289.
- ↑ "www.aace.com" (PDF).